Spring Pharmaceutical Group Analysis

Spring Pharmaceutical Group is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Spring Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Spring Pharmaceutical Group is worth, separate from its market price. There are two main types of Spring Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Spring Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Spring Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Spring Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Spring Pharmaceutical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Spring Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Spring Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Spring Pink Sheet Analysis Notes

About 38.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.01. Some equities with similar Price to Book (P/B) outperform the market in the long run. Spring Pharmaceutical had not issued any dividends in recent years. The entity had 1:28 split on the 26th of November 2007. Spring Pharmaceutical Group, Inc., through its subsidiaries, engages in the research, development, manufacture, and sale of Chinese medicines primarily made from ginseng leaves extract in the Peoples Republic of China. Spring Pharmaceutical Group, Inc. was incorporated in 1989 and is based in Sishui, the Peoples Republic of China. China Yct is traded on OTC Exchange in the United States.The quote for Spring Pharmaceutical Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Spring Pharmaceutical Group please contact Tinghe Yan at 86 53 7426 8278 or go to http://www.yctgroup.com.

Spring Pharmaceutical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Spring Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Spring Pharmaceutical Group or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Spring Pharmaceutical is not yet fully synchronised with the market data
Spring Pharmaceutical has some characteristics of a very speculative penny stock
Spring Pharmaceutical has a very high chance of going through financial distress in the upcoming years
About 38.0% of the company shares are held by company insiders

Spring Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.34 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spring Pharmaceutical's market, we take the total number of its shares issued and multiply it by Spring Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Spring Profitablity

Spring Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Spring Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Spring Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Spring Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Spring Pharmaceutical's profitability requires more research than a typical breakdown of Spring Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 20.41 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 28.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $28.11.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Spring Pharmaceutical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Spring Pink Sheet

If you are still planning to invest in Spring Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spring Pharmaceutical's history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios